There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viking Therapeutics (VKTX – Research Report) and ...

Fintel reports that on April 24, 2025, Maxim Group initiated coverage of Castellum (NYSEAM:CTM) with a Buy recommendation.

Maxim Group analyst Michael Okunewitch maintained a Buy rating on Rezolute (RZLT – Research Report) yesterday and set a price target of $15.00.